JP2022520868A5 - - Google Patents

Info

Publication number
JP2022520868A5
JP2022520868A5 JP2021548668A JP2021548668A JP2022520868A5 JP 2022520868 A5 JP2022520868 A5 JP 2022520868A5 JP 2021548668 A JP2021548668 A JP 2021548668A JP 2021548668 A JP2021548668 A JP 2021548668A JP 2022520868 A5 JP2022520868 A5 JP 2022520868A5
Authority
JP
Japan
Prior art keywords
sequence
seq
cdr
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021548668A
Other languages
English (en)
Japanese (ja)
Other versions
JP7543290B2 (ja
JP2022520868A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019093 external-priority patent/WO2020172450A1/en
Publication of JP2022520868A publication Critical patent/JP2022520868A/ja
Publication of JP2022520868A5 publication Critical patent/JP2022520868A5/ja
Priority to JP2024139367A priority Critical patent/JP7842822B2/ja
Application granted granted Critical
Publication of JP7543290B2 publication Critical patent/JP7543290B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021548668A 2019-02-20 2020-02-20 抗trem2抗体及びその使用方法 Active JP7543290B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024139367A JP7842822B2 (ja) 2019-02-20 2024-08-21 抗trem2抗体及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962808141P 2019-02-20 2019-02-20
US62/808,141 2019-02-20
PCT/US2020/019093 WO2020172450A1 (en) 2019-02-20 2020-02-20 Anti-trem2 antibodies and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024139367A Division JP7842822B2 (ja) 2019-02-20 2024-08-21 抗trem2抗体及びその使用方法

Publications (3)

Publication Number Publication Date
JP2022520868A JP2022520868A (ja) 2022-04-01
JP2022520868A5 true JP2022520868A5 (cg-RX-API-DMAC7.html) 2023-02-27
JP7543290B2 JP7543290B2 (ja) 2024-09-02

Family

ID=69844940

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021548668A Active JP7543290B2 (ja) 2019-02-20 2020-02-20 抗trem2抗体及びその使用方法
JP2024139367A Active JP7842822B2 (ja) 2019-02-20 2024-08-21 抗trem2抗体及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024139367A Active JP7842822B2 (ja) 2019-02-20 2024-08-21 抗trem2抗体及びその使用方法

Country Status (21)

Country Link
US (2) US12240902B2 (cg-RX-API-DMAC7.html)
EP (1) EP3927743A1 (cg-RX-API-DMAC7.html)
JP (2) JP7543290B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210135518A (cg-RX-API-DMAC7.html)
CN (1) CN113614110B (cg-RX-API-DMAC7.html)
AR (1) AR118144A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020226754A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021015656A2 (cg-RX-API-DMAC7.html)
CA (1) CA3130086A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021002206A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021012230A2 (cg-RX-API-DMAC7.html)
EA (1) EA202192294A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP21069105A (cg-RX-API-DMAC7.html)
IL (1) IL285651A (cg-RX-API-DMAC7.html)
MA (1) MA55025A (cg-RX-API-DMAC7.html)
MX (1) MX2021009722A (cg-RX-API-DMAC7.html)
PE (1) PE20211979A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021552002A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202108734VA (cg-RX-API-DMAC7.html)
TW (1) TWI879756B (cg-RX-API-DMAC7.html)
WO (2) WO2020172450A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190248A1 (ar) 2017-04-21 2019-10-20 Amgen Inc بروتينات ربط مولد ضد trem2 واستخداماته
EP3902836B1 (en) * 2018-12-18 2026-03-25 Boehringer Ingelheim IO Canada Inc. Flt3 agonist antibodies and uses thereof
JP7543290B2 (ja) 2019-02-20 2024-09-02 デナリ セラピューティクス インコーポレイテッド 抗trem2抗体及びその使用方法
US11124567B2 (en) 2020-01-13 2021-09-21 Denali Therapeutics Inc. Anti-TREM2 antibodies and methods of use thereof
WO2021146256A1 (en) * 2020-01-13 2021-07-22 Denali Therapeutics Inc. Anti-trem2 antibodies and methods of use thereof
EP4232087A4 (en) * 2020-10-21 2024-10-09 Immune-ONC Therapeutics, Inc. NOVEL ANTI-LILRB2 ANTIBODIES AND DERIVED PRODUCTS
WO2022241082A1 (en) * 2021-05-14 2022-11-17 Genentech, Inc. Agonists of trem2
MX2024010324A (es) 2022-02-23 2024-08-30 Alector Llc Metodos de uso de anticuerpos anti-trem2.
EP4499693A1 (en) 2022-03-28 2025-02-05 Denali Therapeutics Inc. Monovalent anti-trem2 binding molecules and methods of use thereof
EP4499695A1 (en) 2022-03-28 2025-02-05 Denali Therapeutics Inc. Methods for treating brain glucose hypometabolism
JP2026505005A (ja) 2023-01-30 2026-02-10 イーエスアーエル バイオサイエンス ゲゼルシャフト ミット ベシュレンクテル ハフツング 神経変性障害を治療するためのヒト抗trem2抗体
AU2024320793A1 (en) 2023-08-09 2026-03-12 F. Hoffmann-La Roche Ag Mono and multispecific anti-trem2 antibodies, methods and uses thereof
AU2024323186A1 (en) 2023-08-09 2026-01-15 F. Hoffmann-La Roche Ag Mono and multispecific anti-trem2 antibodies, methods and uses thereof
WO2025046298A2 (en) 2023-09-01 2025-03-06 iTeos Belgium SA Anti-trem2 antibodies and methods of use
KR20260113065A (ko) * 2023-11-15 2026-07-21 머크 샤프 앤드 돔 엘엘씨 인간 넥틴-4 결합제

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231878B2 (en) 2001-03-20 2012-07-31 Cosmo Research & Development S.P.A. Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
RU2011133071A (ru) 2009-01-06 2013-02-20 Нестек С.А. Переработка макронутриентов
NZ594514A (en) 2009-03-05 2013-06-28 Abbott Lab Interleukin-17 BINDING PROTEINS
US10087408B2 (en) 2010-07-07 2018-10-02 The University Of British Columbia System and method for microfluidic cell culture
US9188593B2 (en) 2010-07-16 2015-11-17 The University Of British Columbia Methods for assaying cellular binding interactions
WO2012176779A1 (ja) * 2011-06-20 2012-12-27 協和発酵キリン株式会社 抗erbB3抗体
CA2909952C (en) 2013-04-29 2021-10-12 Teva Pharmaceuticals Australia Pty Ltd. Anti-cd38 antibodies and fusions to attenuated interferon alpha-2b
EP3041865A2 (en) 2013-09-03 2016-07-13 NovImmune S.A. Readily isolated bispecific binding molecules with native format having mutated constant regions
CN105218669A (zh) 2014-06-10 2016-01-06 河北翰林生物科技有限公司 制备抗人r47h-trem2突变体的人单克隆抗体的方法
EA201790342A1 (ru) * 2014-08-08 2017-07-31 ЭЛЕКТОР ЭлЭлСи Антитела к trem2 и способы их применения
KR20240056629A (ko) 2014-09-28 2024-04-30 더 리전트 오브 더 유니버시티 오브 캘리포니아 자극성 및 비자극성 골수성 세포의 조절
JP6996979B2 (ja) * 2015-03-31 2022-02-04 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト 三量体tnfファミリーリガンドを含む抗原結合分子
WO2017058866A1 (en) * 2015-09-28 2017-04-06 Precision Immune, Inc. Anti-trem2 antibodies and uses thereof
JP7725185B2 (ja) * 2015-10-06 2025-08-19 アレクトル エルエルシー 抗trem2抗体及びその使用方法
WO2017147509A1 (en) 2016-02-25 2017-08-31 Marco Colonna Compositions comprising trem2 and methods of use thereof
EP3448874A4 (en) 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
JP2019531332A (ja) 2016-07-22 2019-10-31 ドイチェス ツェントルム フュール ノイロデゲネラティフェ アークランクンゲン エー.ファウ.(デーツェットエンエー) Trem2切断モジュレーター及びその使用
CN118271442A (zh) 2016-12-23 2024-07-02 蓝鳍生物医药公司 抗sez6l2抗体和抗体药物缀合物
US20190367623A1 (en) 2017-01-17 2019-12-05 Yeda Research And Development Co. Ltd. Methods of treating neurodegenerative diseases by inducing disease-associated microglia (dam) cells
CA3053379A1 (en) 2017-02-17 2018-08-23 Denali Therapeutics Inc. Anti-tau antibodies and methods of use thereof
CA3053381A1 (en) 2017-02-17 2018-08-23 Denali Therapeutics Inc. Engineered polypeptides
RS63818B1 (sr) 2017-02-17 2023-01-31 Denali Therapeutics Inc Konstruisani polipeptidi za vezivanje za receptor transferina
JOP20190248A1 (ar) * 2017-04-21 2019-10-20 Amgen Inc بروتينات ربط مولد ضد trem2 واستخداماته
BR112020001060A2 (pt) 2017-07-27 2020-07-14 Novartis Ag variantes de trem2 resistentes a shedase
HUE062436T2 (hu) * 2017-08-03 2023-11-28 Alector Llc Anti-trem2 antitestek és alkalmazási módszereik
WO2019032955A1 (en) 2017-08-10 2019-02-14 Denali Therapeutics Inc. MODIFIED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES
WO2019055841A1 (en) 2017-09-14 2019-03-21 Denali Therapeutics Inc. ANTI-TREM2 ANTIBODIES AND METHODS OF USE
BR112020005271A2 (pt) 2017-10-02 2020-09-15 Denali Therapeutics Inc. proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica
WO2019079529A1 (en) 2017-10-17 2019-04-25 The Translational Genomics Research Institute TREM2 AGONISTS FOR STIMULATING MICROGLIA AND IDENTIFICATION METHODS
WO2019094608A1 (en) 2017-11-08 2019-05-16 Denali Therapeutics Inc. Anti-bace1 antibodies and methods of use thereof
MX2020006213A (es) 2017-12-12 2020-09-14 Pionyr Immunotherapeutics Inc Anticuerpos anti-trem2 y metodos relacionados.
BR112020013921A2 (pt) 2018-01-10 2020-12-01 Denali Therapeutics Inc. polipeptídeos de ligação ao receptor de transferrina e usos destes
WO2019246071A1 (en) 2018-06-18 2019-12-26 Denali Therapeutics Inc. Fusion proteins comprising progranulin
GB201811404D0 (en) 2018-07-12 2018-08-29 F Star Beta Ltd Anti-CD137 Antibodies
CA3109763A1 (en) 2018-08-16 2020-02-20 Denali Therapeutics Inc. Engineered bispecific proteins
EP3840781A1 (en) 2018-08-22 2021-06-30 Denali Therapeutics Inc. Anti-her2 polypeptides and methods of use thereof
SG11202102162RA (en) 2018-09-11 2021-04-29 Univ Washington Anti-trem-2 agonist antibodies
UY38407A (es) 2018-10-15 2020-05-29 Novartis Ag Anticuerpos estabilizadores de trem2
KR102156165B1 (ko) 2018-10-29 2020-09-15 재단법인대구경북과학기술원 인간 trem2 세포막 단백질에 대한 단일클론항체, 이를 생산하는 하이브리도마 세포주 및 이의 용도
CN113302206A (zh) 2018-11-26 2021-08-24 戴纳立制药公司 治疗脂质代谢失调的方法
EP3894864A2 (en) 2018-12-10 2021-10-20 Denali Therapeutics Inc. Lysosomal storage disorder biomarkers and methods of use thereof
CA3122725A1 (en) 2018-12-10 2020-06-18 Mor Research Applications Trem2 antibodies and uses thereof
CA3120875A1 (en) 2018-12-11 2020-06-18 Pionyr Immunotherapeutics, Inc. Methods of using anti-trem2 antibodies
JP7543290B2 (ja) 2019-02-20 2024-09-02 デナリ セラピューティクス インコーポレイテッド 抗trem2抗体及びその使用方法
WO2020194317A1 (en) 2019-03-28 2020-10-01 Yeda Research And Development Co. Ltd. Method of treating lipid-related disorders
AU2020252554B2 (en) 2019-04-03 2026-05-28 Denali Therapeutics Inc. Formulations of protein molecules comprising iduronate 2-sulfatase
BR112022012230A2 (pt) 2019-12-23 2022-08-30 Denali Therapeutics Inc Variantes de progranulina
WO2021146256A1 (en) 2020-01-13 2021-07-22 Denali Therapeutics Inc. Anti-trem2 antibodies and methods of use thereof
US11124567B2 (en) 2020-01-13 2021-09-21 Denali Therapeutics Inc. Anti-TREM2 antibodies and methods of use thereof
WO2021158986A1 (en) 2020-02-07 2021-08-12 Denali Therapeutics Inc. Methods for the treatment of hunter syndrome
CA3170338A1 (en) 2020-02-19 2021-08-26 Denali Therapeutics Inc. Engineered anti-her2 bispecific proteins
CR20230178A (es) 2020-10-14 2023-07-26 Denali Therapeutics Inc Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas

Similar Documents

Publication Publication Date Title
JP2023512450A5 (cg-RX-API-DMAC7.html)
JP7046804B2 (ja) 改良された血清アルブミン結合剤
CN109608544B (zh) Pd-l1抗体、其抗原结合片段及其医药用途
TWI508745B (zh) TNF-α結合蛋白
KR101498833B1 (ko) 항―N3pGlu 아밀로이드 베타 펩티드 항체 및 그의 용도
RU2609627C2 (ru) Высокоаффинные и агрегационно стабильные антитела на основе вариабельных доменов vl и производного vhh
US20230265178A1 (en) Modified immunoglobulins for targeting amyloid deposits
JP2020517249A5 (cg-RX-API-DMAC7.html)
JP2014503202A (ja) TNF−α結合性タンパク質
JP2016147902A5 (cg-RX-API-DMAC7.html)
RU2008149918A (ru) Антитела к nkg2a и их применения
JP2008505610A5 (cg-RX-API-DMAC7.html)
HRP20192267T1 (hr) Terapeutski agens ili profilaktički agens za demenciju
JP2024518545A5 (cg-RX-API-DMAC7.html)
IL275223B1 (en) Anti-alpha-synuclein antibodies
JP2022513043A5 (cg-RX-API-DMAC7.html)
JP2023549555A5 (cg-RX-API-DMAC7.html)
TW201134489A (en) Basigin binding proteins
CN113227148B (zh) 抗gpc3抗体、其抗原结合片段及其医药用途
CN116368153A (zh) Zip12抗体
JP2024511027A (ja) 幹細胞因子抗体及びその使用方法
JP2023531822A (ja) タウ結合分子
WO2018228406A1 (zh) Pcsk9抗体、其抗原结合片段及其医药用途
JP2024543828A5 (cg-RX-API-DMAC7.html)
US12448441B2 (en) ZIP12 antibody